AKUMS DRUGS & PHARMACEUTICALS
Back to All Ratios
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Core EBITDA Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Core EBITDA Margin(%) | 11.18 | 2.94 | 8.04 | -2.50 | 10.69 |
What is the latest Core EBITDA Margin ratio of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Core EBITDA Margin |
|---|---|
| Mar2025 | 11.18 |
| Mar2024 | 2.94 |
| Mar2023 | 8.04 |
| Mar2022 | -2.50 |
| Mar2021 | 10.69 |
How is Core EBITDA Margin of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Core EBITDA Margin | % Change | |
|---|---|---|---|
| Mar2025 | 11.18 | 280.27 | |
| Mar2024 | 2.94 | -63.43 | |
| Mar2023 | 8.04 | Positive | |
| Mar2022 | -2.5 | Negative | |
| Mar2021 | 10.69 | - | |
Other Financial Ratios of AKUMS DRUGS & PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Margin ratio of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹8,592.5 Cr | 5.9% | 15.9% | 28.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 5.9% |
15.9% |
28.2% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses